-- Really "the best"? Or just good, on a disease that's easily treated? --> These patients were treated with the recombinant immunotoxin, BL22, which targets the CD22 cell surface receptor, which is highly expressed on these leukemic cells.
•
Antibody-drug conjugates, most, if not all, are immunotoxins but use whole antibodies and non-protein drugs
Immunopharmacology and Immunotoxicology is a bimonthly peer-reviewed medical journal that covers preclinical and clinical studies on the regulatory effects of various agents on immunocompetent cells, as well as the immunotoxicity exerted by xenobiotics and drugs.